Google Übersetzer
Sanara Medtech Inc.
About
23.51USD+0.13 +0.53%
Closed • Updated at 17:57 GMT+00:00Market Cap$215.40M
Volume15.6K
Beta2.06
RSI66.92
Gross Margin90.15%
Sanara Medtech Inc. — investor relations, events, news, and company updates on 6ix.
Latest News
May 11 2026
Sanara MedTech Inc. Reports First Quarter 2026 Financial Results (Unaudited)
Apr 14 2026
Sanara MedTech Inc. to Report First Quarter 2026 Financial Results on May 12, 2026
Mar 24 2026
Sanara MedTech Inc. Reports Fourth Quarter (Unaudited) and Full Year 2025 Financial Results; Reaffirmed Full Year 2026 Financial Guidance
Mar 11 2026
Sanara MedTech Inc. Announces Publication of Peer-Reviewed Study Evaluating the Economic and Clinical Value of CellerateRX® Surgical Powder in the Management of Spine Surgery Wounds
Mar 3 2026
Sanara MedTech Inc. to Report Fourth Quarter and Full Year 2025 Financial Results on March 24, 2026
Recent Videos
Sanara MedTech Q1 2026 Earnings Call | CellerateRX Sales Grow 30% As Surgical Site Expansion Scales
May 13, 2026
SMTI STOCK : POTENTIAL BOUNCEBACK | SANARA MEDTECH STOCK
May 13, 2026
Sanara MedTech (SMTI) hits 93% gross margins — full stock analysis and valuation deep dive
Apr 26, 2026
Sanara Medtech Valuation: The 93% Margin Disconnect
Mar 25, 2026
Community Chat
Ask AI
Try asking